The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with nonalcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis
Titel:
The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with nonalcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis
Auteur:
Abdelmalek, Manal F. Charles, Edgar D. Sanyal, Arun J. Harrison, Stephen A. Neuschwander-Tetri, Brent A. Goodman, Zachary Ehman, Richard A. Karsdal, Morten Nakajima, Atsushi Du, Shuyan Tirucherai, Giridhar S. Klinger, George H. Mora, Johanna Yamaguchi, Masayuki Shevell, Diane E. Loomba, Rohit